secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001654954-24-013505
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders approve 7.9M share increase in 2022 Stock Incentive Plan
---------------------------------------------------------------------

- Approved Amendment No. 2 to 2022 Stock Incentive Plan, increasing authorized shares to 8,336,600 (7,935,912 new shares).
- Vote: 1,176,335 for, 157,003 against, 3,849 abstentions; no broker non-votes.
- Board approved amendment on Sept 6, 2024; stockholders approved on Oct 25, 2024.
- Adjournment proposal also approved: 1,194,879 for, 139,002 against, 3,306 abstentions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/0001654954-24-013505-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495424013505/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-013505

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer